Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.
Financial Results:
Global Health Ltd reported Revenues for Q3FY25 of ₹943.00 Crores up from ₹836.00 Crore year on year, a rise of 12.8%.
Total Expenses for Q3FY25 of ₹770.00 Crores up from ₹682.00 Crores year on year, a rise of 12.9%.
Consolidated Net Profit of ₹143.00 Crores up 15.32% from ₹124.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹5.32, up 15.40% from ₹4.61 in the same quarter of the previous year.
![](data:image/svg+xml;charset=utf-8,<svg height="781px" width="640px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
